The evaluation of T cells from individuals convalescing for COVID-19 against stimulation with different SARS-CoV-2 peptides, for example, indicated the persistence of a robust cellular response, strongly characterized by the CD8+ T lymphocyte compartment (7). This evidence concerns the gene CD8A and COVID-19.